Literature DB >> 9886359

The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat.

C A Davies1, S A Loddick, S Toulmond, R P Stroemer, J Hunt, N J Rothwell.   

Abstract

The cytokine interleukin-1 (IL-1) has been implicated in the exacerbation of ischemic damage in the brains of rodents. This study has ascertained the cellular localization and chronologic and topographic distribution of pro/mature interleukin-1beta (IL-1beta) protein 0.5, 1, 2, 6, 24, and 48 hours after ischemia by subjecting rats to permanent unilateral occlusion of the middle cerebral artery. Interleukin-1beta was localized immunocytochemically in vibratome sections of perfusion-fixed brains. The cells that expressed IL-1beta had the morphologic features of microglia and macrophages. Interleukin-1beta was first detected 1 hour after occlusion in ipsilateral meningeal macrophage-like cells. By 6 hours, pro/mature IL-1beta-immunoreactive (IL-1(beta)ir) putative microglia were present in the ischemic cerebral cortex, corpus callosum, caudoputamen, and surrounding tissue. By 24 and 48 hours after ischemia, the number and spread of IL-1(beta)ir cells increased greatly, including those resembling activated microglia and macrophages, as the core of the infarct became infiltrated. Interleukin-1(beta)ir cells also were present in apparently undamaged tissue, adjacent to the lesion ipsilaterally, and contralaterally in the cerebral cortex, dorsal corpus callosum, dorsal caudoputamen, and hippocampus. These results support the functional role of IL-1 in ischemic brain damage and reveal a distinct temporal and spatial expression of IL-1beta protein in cells believed to be microglia and macrophages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886359     DOI: 10.1097/00004647-199901000-00010

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  54 in total

Review 1.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

Review 2.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

Review 3.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

4.  Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

Authors:  Omar Touzani; Herve Boutin; Rosalind LeFeuvre; Lisa Parker; Andy Miller; Giamal Luheshi; Nancy Rothwell
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

Review 5.  Role of microglia in neuronal degeneration and regeneration.

Authors:  Lisa Walter; Harald Neumann
Journal:  Semin Immunopathol       Date:  2009-09-09       Impact factor: 9.623

Review 6.  Annual review prize lecture cytokines - killers in the brain?

Authors:  N J Rothwell
Journal:  J Physiol       Date:  1999-01-01       Impact factor: 5.182

Review 7.  Inflammation, mitochondria, and the inhibition of adult neurogenesis.

Authors:  Ludmila A Voloboueva; Rona G Giffard
Journal:  J Neurosci Res       Date:  2011-09-09       Impact factor: 4.164

Review 8.  Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

Authors:  Changjun Yang; Kimberly E Hawkins; Sylvain Doré; Eduardo Candelario-Jalil
Journal:  Am J Physiol Cell Physiol       Date:  2018-10-31       Impact factor: 4.249

9.  Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease.

Authors:  Kwaku Asare; Beatrice E Gee; Jonathan K Stiles; Nana O Wilson; Adel Driss; Alexander Quarshie; Robert J Adams; Abdullah Kutlar; Jacqueline M Hibbert
Journal:  Cytokine       Date:  2009-11-08       Impact factor: 3.861

Review 10.  The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

Authors:  Herve Boutin; Ian Kimber; Nancy J Rothwell; Emmanuel Pinteaux
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.